Tumour necrosis factor alpha, interferon gamma and substance P are novel modulators of extrapituitary prolactin expression in human skin.

PubWeight™: 0.76‹?›

🔗 View Article (PMC 3634033)

Published in PLoS One on April 23, 2013

Authors

Ewan A Langan1, Silvia Vidali, Natascha Pigat, Wolfgang Funk, Erika Lisztes, Tamás Bíró, Vincent Goffin, Christopher E M Griffiths, Ralf Paus

Author Affiliations

1: Dermatology Research Centre, Manchester Academic Health Science Centre, and Institute of Inflammation and Repair, University of Manchester, Manchester, United Kingdom.

Articles cited by this

Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev (1997) 5.57

Pathogenesis and clinical features of psoriasis. Lancet (2007) 5.01

Prolactin: structure, function, and regulation of secretion. Physiol Rev (2000) 4.95

Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev (1998) 3.82

Neuroendocrinology of the skin. Endocr Rev (2000) 3.34

Sensing the environment: regulation of local and global homeostasis by the skin's neuroendocrine system. Adv Anat Embryol Cell Biol (2012) 2.99

What can we learn from rodents about prolactin in humans? Endocr Rev (2007) 2.38

Human hair follicles display a functional equivalent of the hypothalamic-pituitary-adrenal axis and synthesize cortisol. FASEB J (2005) 2.23

Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects. Endocr Rev (1996) 1.89

Cytokine mRNA levels in Alopecia areata before and after treatment with the contact allergen diphenylcyclopropenone. J Invest Dermatol (1994) 1.76

Further exploring the brain-skin connection: stress worsens dermatitis via substance P-dependent neurogenic inflammation in mice. J Invest Dermatol (2007) 1.67

Alternative splicing of CRH-R1 receptors in human and mouse skin: identification of new variants and their differential expression. FASEB J (2001) 1.59

Prolactin receptor antagonism in mouse anterior pituitary: effects on cell turnover and prolactin receptor expression. Am J Physiol Endocrinol Metab (2011) 1.45

Thyrotropin-releasing hormone selectively stimulates human hair follicle pigmentation. J Invest Dermatol (2011) 1.43

Increased expression of prolactin receptor gene assessed by quantitative polymerase chain reaction in human breast tumors versus normal breast tissues. J Clin Endocrinol Metab (1998) 1.31

New concepts in prolactin biology. J Endocrinol (2010) 1.26

Nonpituitary human prolactin gene transcription is independent of Pit-1 and differentially controlled in lymphocytes and in endometrial stroma. Mol Endocrinol (1994) 1.24

Neuroendocrine system of the skin. Dermatology (2005) 1.24

Serial cultivation of single keratinocytes from the outer root sheath of human scalp hair follicles. J Invest Dermatol (1986) 1.20

Prolactin in man: a tale of two promoters. Bioessays (2006) 1.20

Thyroid hormones directly alter human hair follicle functions: anagen prolongation and stimulation of both hair matrix keratinocyte proliferation and hair pigmentation. J Clin Endocrinol Metab (2008) 1.15

Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β. Br J Dermatol (2011) 1.14

Development of pure prolactin receptor antagonists. J Biol Chem (2003) 1.11

Effects of interleukins, colony-stimulating factor and tumour necrosis factor on human hair follicle growth in vitro: a possible role for interleukin-1 and tumour necrosis factor-alpha in alopecia areata. Br J Dermatol (1996) 1.04

Anterior pituitary hormones, stress, and immune system homeostasis. Bioessays (2001) 1.02

Prolactin and the skin: a dermatological perspective on an ancient pleiotropic peptide hormone. J Invest Dermatol (2008) 1.01

Collapse and restoration of MHC class-I-dependent immune privilege: exploiting the human hair follicle as a model. Am J Pathol (2004) 1.01

Prolactin expression and secretion by human breast glandular and adipose tissue explants. J Clin Endocrinol Metab (2003) 1.01

Towards the development of a simplified long-term organ culture method for human scalp skin and its appendages under serum-free conditions. Exp Dermatol (2007) 0.99

Interferon-gamma is a potent inducer of catagen-like changes in cultured human anagen hair follicles. Br J Dermatol (2005) 0.98

Prolactin enhances interferon-gamma-induced production of CXC ligand 9 (CXCL9), CXCL10, and CXCL11 in human keratinocytes. Endocrinology (2007) 0.98

Characterization of a prolactin gene polymorphism and its associations with systemic lupus erythematosus. Arthritis Rheum (2001) 0.98

Probing the effects of stress mediators on the human hair follicle: substance P holds central position. Am J Pathol (2007) 0.97

The expression of proopiomelanocortin (POMC) and of corticotropin releasing hormone receptor (CRH-R) genes in mouse skin. Biochim Biophys Acta (1996) 0.96

The human skin as a hormone target and an endocrine gland. Hormones (Athens) (2006) 0.95

Thyrotropin releasing hormone (TRH): a new player in human hair-growth control. FASEB J (2009) 0.95

Thyroid-stimulating hormone, a novel, locally produced modulator of human epidermal functions, is regulated by thyrotropin-releasing hormone and thyroid hormones. Endocrinology (2010) 0.94

Human scalp hair follicles are both a target and a source of prolactin, which serves as an autocrine and/or paracrine promoter of apoptosis-driven hair follicle regression. Am J Pathol (2006) 0.92

Prolactin and its receptor are expressed in murine hair follicle epithelium, show hair cycle-dependent expression, and induce catagen. Am J Pathol (2003) 0.92

Re-evaluation of the prolactin receptor expression in human breast cancer. J Endocrinol (2009) 0.91

Prolactin: does it have a role in the pathogenesis of psoriasis? Dermatology (1998) 0.91

Hair loss and hyperprolactinemia in women. Dermatoendocrinol (2012) 0.90

Prolactin--a novel neuroendocrine regulator of human keratin expression in situ. FASEB J (2010) 0.89

Dopamine receptors in human adipocytes: expression and functions. PLoS One (2011) 0.87

Prolactin pulsatile characteristics in postmenopausal women. J Clin Endocrinol Metab (1998) 0.87

P-cadherin regulates human hair growth and cycling via canonical Wnt signaling and transforming growth factor-β2. J Invest Dermatol (2012) 0.87

Prolactin enhances basal and IL-17-induced CCL20 production by human keratinocytes. Eur J Immunol (2009) 0.86

Immunolocalisation of the janus kinases (JAK)--signal transducers and activators of transcription (STAT) pathway in human epidermis. J Anat (2001) 0.86

Hiding under the skin: A welcome surprise in psoriasis. Nat Med (2012) 0.86

Polymorphisms of the human prolactin gene--implications for production of lymphocyte prolactin and systemic lupus erythematosus. Lupus (2001) 0.86

Failure of bromocriptine, dopamine, and thyrotropin-releasing hormone to affect prolactin secretion by human decidual tissue in vitro. J Clin Endocrinol Metab (1979) 0.86

Human dermal fibroblast cells express prolactin in vitro. J Invest Dermatol (1996) 0.85

Human female hair follicles are a direct, nonclassical target for thyroid-stimulating hormone. J Invest Dermatol (2008) 0.85

Growth hormone and prolactin responses to corticotrophin-releasing-hormone in patients with Cushing's disease: a paracrine action of the adenomatous corticotrophic cells? Clin Endocrinol (Oxf) (1998) 0.84

Exploring the role of prolactin in psoriasis. Arch Dermatol Res (2012) 0.83

Prolactin level is significantly elevated in lesional skin of patients with psoriasis. Int J Dermatol (2011) 0.83

Prolactin: an emerging force along the cutaneous-endocrine axis. Trends Endocrinol Metab (2010) 0.82

The stimulatory and inhibitory effects of dopamine on prolactin secretion involve different G-proteins. Endocrinology (1992) 0.82

Neuroendocrinology of the skin: An overview and selective analysis. Dermatoendocrinol (2011) 0.81

Human skin expresses growth hormone but not the prolactin gene. J Lab Clin Med (2000) 0.81

Psoriasis in association with prolactinoma: three cases. Br J Dermatol (2000) 0.80

Prolactin stimulates proliferation of cultured human keratinocytes. J Invest Dermatol (1993) 0.80

Serum prolactin levels in psoriasis and correlation with cutaneous disease activity. Clin Exp Dermatol (2011) 0.79

Thyrotropin-releasing hormone and oestrogen differentially regulate prolactin and prolactin receptor expression in female human skin and hair follicles in vitro. Br J Dermatol (2010) 0.79

Mind the (gender) gap: does prolactin exert gender and/or site-specific effects on the human hair follicle? J Invest Dermatol (2009) 0.78

Clinical efficacy of propylthiouracil and its influence on prolactin in psoriatic patients. Clin Biochem (2011) 0.78

The human prolactin receptor in the fetal membranes, decidua, and placenta. J Clin Endocrinol Metab (1996) 0.78

Involvement of nitric oxide in the interferon-gamma-induced inhibition of growth hormone and prolactin secretion in anterior pituitary cell cultures. Mol Cell Endocrinol (1997) 0.78

Role of prolactin and vasoinhibins in the regulation of vascular function in mammary gland. J Mammary Gland Biol Neoplasia (2008) 0.78

Effect of corticotropin-releasing factor on the release and synthesis of prolactin. Neuroendocrinology (1989) 0.77

Effect of interferon-gamma treatment on 24-hour variations in plasma ACTH, growth hormone, prolactin, luteinizing hormone and follicle-stimulating hormone of male rats. Neuroimmunomodulation (2005) 0.77

Utilizing the hair follicle to dissect the regulation and autocrine/paracrine activities of prolactin in humans. Am J Physiol Endocrinol Metab (2012) 0.76

Physiologically significant inhibitory hypothalamic action of substance P on prolactin release in the male rat. Neuroendocrinology (1990) 0.76

No evidence for involvement of the growth hormone/insulin-like growth factor-1 axis in psoriasis. J Invest Dermatol (1997) 0.76

The interferon family stimulates the secretions of prolactin and interleukin-6 by the pituitary gland in vitro. J Endocrinol Invest (1991) 0.76

In search of the source of hyperprolactinaemia in systemic lupus erythematosus. Clin Exp Rheumatol (2011) 0.76

Dopamine is a novel, direct inducer of catagen in human scalp hair follicles in vitro. Br J Dermatol (2012) 0.75

Female pattern hair loss: beyond an androgenic aetiology? Br J Dermatol (2010) 0.75

Prolonged effects of tumor necrosis factor-alpha on anterior pituitary hormone release. Peptides (1995) 0.75

Articles by these authors

A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet (2010) 8.48

Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol (2012) 4.52

Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat Genet (2012) 4.13

Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial. Lancet (2005) 3.59

Secukinumab in plaque psoriasis--results of two phase 3 trials. N Engl J Med (2014) 3.36

An international, randomized, double-blind, placebo-controlled phase 3 trial of intramuscular alefacept in patients with chronic plaque psoriasis. Arch Dermatol (2003) 3.28

Molecular principles of hair follicle induction and morphogenesis. Bioessays (2005) 3.08

Association between the PTPN22 gene and rheumatoid arthritis and juvenile idiopathic arthritis in a UK population: further support that PTPN22 is an autoimmunity gene. Arthritis Rheum (2005) 2.93

Genome-wide association study in alopecia areata implicates both innate and adaptive immunity. Nature (2010) 2.85

Alopecia areata. N Engl J Med (2012) 2.56

The hair follicle as a dynamic miniorgan. Curr Biol (2009) 2.52

Exploring the "hair growth-wound healing connection": anagen phase promotes wound re-epithelialization. J Invest Dermatol (2010) 2.48

Identification of ZNF313/RNF114 as a novel psoriasis susceptibility gene. Hum Mol Genet (2008) 2.42

A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone. Nat Genet (2004) 2.30

IL-15/IL-15 receptor biology: a guided tour through an expanding universe. Cytokine Growth Factor Rev (2006) 2.29

Transient receptor potential channels as therapeutic targets. Nat Rev Drug Discov (2011) 2.25

Human hair follicles display a functional equivalent of the hypothalamic-pituitary-adrenal axis and synthesize cortisol. FASEB J (2005) 2.23

Reciprocal requirements for EDA/EDAR/NF-kappaB and Wnt/beta-catenin signaling pathways in hair follicle induction. Dev Cell (2009) 2.17

Cdc42 controls progenitor cell differentiation and beta-catenin turnover in skin. Genes Dev (2006) 2.10

Noninvasive measurement of skin autofluorescence is increased in patients with systemic sclerosis: an indicator of increased advanced glycation endproducts? J Rheumatol (2012) 2.03

IL-15 constrains mast cell-dependent antibacterial defenses by suppressing chymase activities. Nat Med (2007) 2.00

Frontiers in pruritus research: scratching the brain for more effective itch therapy. J Clin Invest (2006) 1.90

Hair follicle pigmentation. J Invest Dermatol (2005) 1.84

Single-nucleotide polymorphisms of vascular endothelial growth factor in psoriasis of early onset. J Invest Dermatol (2004) 1.84

Differential expression of HPA axis homolog in the skin. Mol Cell Endocrinol (2006) 1.72

Retracted A promiscuous liaison between IL-15 receptor and Axl receptor tyrosine kinase in cell death control. EMBO J (2005) 1.72

Neuroimmunology of stress: skin takes center stage. J Invest Dermatol (2006) 1.72

The interleukin-15/interleukin-15 receptor system as a model for juxtacrine and reverse signaling. Bioessays (2006) 1.70

Genetic analysis of PSORS1 distinguishes guttate psoriasis and palmoplantar pustulosis. J Invest Dermatol (2003) 1.68

NF-kappaB transmits Eda A1/EdaR signalling to activate Shh and cyclin D1 expression, and controls post-initiation hair placode down growth. Development (2006) 1.66

Local prolactin is a target to prevent expansion of basal/stem cells in prostate tumors. Proc Natl Acad Sci U S A (2010) 1.62

Neuronal plasticity of the "brain-skin connection": stress-triggered up-regulation of neuropeptides in dorsal root ganglia and skin via nerve growth factor-dependent pathways. J Mol Med (Berl) (2007) 1.58

Lymphocytes, neuropeptides, and genes involved in alopecia areata. J Clin Invest (2007) 1.56

Cylindroma as tumor of hair follicle origin. J Invest Dermatol (2006) 1.56

Neurophysiological, neuroimmunological, and neuroendocrine basis of pruritus. J Invest Dermatol (2006) 1.53

Solution structure of human prolactin. J Mol Biol (2005) 1.52

Mast cells are required for normal healing of skin wounds in mice. FASEB J (2006) 1.50

Circadian clock genes contribute to the regulation of hair follicle cycling. PLoS Genet (2009) 1.49

Beyond wavy hairs: the epidermal growth factor receptor and its ligands in skin biology and pathology. Am J Pathol (2008) 1.47

Prolactin receptor antagonism in mouse anterior pituitary: effects on cell turnover and prolactin receptor expression. Am J Physiol Endocrinol Metab (2011) 1.45

Polymorphisms in the IL-12beta and IL-23R genes are associated with psoriasis of early onset in a UK cohort. J Invest Dermatol (2007) 1.44

Application of new homologous in vitro bioassays for human lactogens to assess the actual bioactivity of human prolactin isoforms in hyperprolactinaemic patients. Clin Endocrinol (Oxf) (2006) 1.44

Immunophenotyping of the human bulge region: the quest to define useful in situ markers for human epithelial hair follicle stem cells and their niche. Exp Dermatol (2008) 1.43

Thyrotropin-releasing hormone selectively stimulates human hair follicle pigmentation. J Invest Dermatol (2011) 1.43

Beyond skin: the need for a new approach to the management of psoriasis in primary care. Br J Gen Pract (2012) 1.42

Polyubiquitination of prolactin receptor stimulates its internalization, postinternalization sorting, and degradation via the lysosomal pathway. Mol Cell Biol (2008) 1.41

Psychologic factors in psoriasis: consequences, mechanisms, and interventions. Dermatol Clin (2005) 1.36

Molecular biology of hair morphogenesis: development and cycling. J Exp Zool B Mol Dev Evol (2003) 1.36

Challenges and approaches for the development of safer immunomodulatory biologics. Nat Rev Drug Discov (2013) 1.35

Neuropeptide control mechanisms in cutaneous biology: physiological and clinical significance. J Invest Dermatol (2006) 1.33

Plasticity and cytokinetic dynamics of the hair follicle mesenchyme: implications for hair growth control. J Invest Dermatol (2003) 1.32

Rare pathogenic variants in IL36RN underlie a spectrum of psoriasis-associated pustular phenotypes. J Invest Dermatol (2013) 1.32

Glucocorticoid sensitivity is determined by a specific glucocorticoid receptor haplotype. J Clin Endocrinol Metab (2004) 1.29

Current and future management of psoriasis. Lancet (2007) 1.29

The PKC inhibitor AEB071 may be a therapeutic option for psoriasis. J Clin Invest (2008) 1.27

A hot new twist to hair biology: involvement of vanilloid receptor-1 (VR1/TRPV1) signaling in human hair growth control. Am J Pathol (2005) 1.27

Psychological distress impairs clearance of psoriasis in patients treated with photochemotherapy. Arch Dermatol (2003) 1.26

Migration of melanoblasts into the developing murine hair follicle is accompanied by transient c-Kit expression. J Histochem Cytochem (2002) 1.26

New concepts in prolactin biology. J Endocrinol (2010) 1.26

Epidermal Langerhans cell migration and sensitisation to chemical allergens. APMIS (2003) 1.25

Burden of hair loss: stress and the underestimated psychosocial impact of telogen effluvium and androgenetic alopecia. J Invest Dermatol (2004) 1.24

Why some women look young for their age. PLoS One (2009) 1.24

Noninvasive imaging techniques in the assessment of scleroderma spectrum disorders. Arthritis Rheum (2009) 1.23

Runx1 directly promotes proliferation of hair follicle stem cells and epithelial tumor formation in mouse skin. Mol Cell Biol (2010) 1.23

Exploring the role of stem cells in cutaneous wound healing. Exp Dermatol (2009) 1.23

The WSXWS motif in cytokine receptors is a molecular switch involved in receptor activation: insight from structures of the prolactin receptor. Structure (2012) 1.22

Stress inhibits hair growth in mice by induction of premature catagen development and deleterious perifollicular inflammatory events via neuropeptide substance P-dependent pathways. Am J Pathol (2003) 1.22

Developmental timing of hair follicle and dorsal skin innervation in mice. J Comp Neurol (2002) 1.20

The mesenchymal component of hair follicle neogenesis: background, methods and molecular characterization. Exp Dermatol (2009) 1.20

Melatonin in the skin: synthesis, metabolism and functions. Trends Endocrinol Metab (2007) 1.20

Skin as an endocrine organ: implications for its function. Drug Discov Today Dis Mech (2008) 1.19

Autocrine prolactin promotes prostate cancer cell growth via Janus kinase-2-signal transducer and activator of transcription-5a/b signaling pathway. Endocrinology (2007) 1.19

Maintenance of hair follicle immune privilege is linked to prevention of NK cell attack. J Invest Dermatol (2007) 1.18

TRPV3: time to decipher a poorly understood family member! J Physiol (2013) 1.18

Control of pelage hair follicle development and cycling by complex interactions between follistatin and activin. FASEB J (2003) 1.17

Prolactin modulates TRPV1 in female rat trigeminal sensory neurons. J Neurosci (2006) 1.17

Associations between ultraviolet radiation, basal cell carcinoma site and histology, host characteristics, and rate of development of further tumors. J Am Acad Dermatol (2005) 1.17

Impaired Langerhans cell migration in psoriasis. J Exp Med (2006) 1.16

p75 Neurotrophin receptor antagonist retards apoptosis-driven hair follicle involution (catagen). J Invest Dermatol (2003) 1.16

Dendritic cell-derived IL-15 controls the induction of CD8 T cell immune responses. Eur J Immunol (2003) 1.16

Evidence for common genetic control in pathways of inflammation for Crohn's disease and psoriatic arthritis. Arthritis Rheum (2005) 1.16

Thyroid hormones directly alter human hair follicle functions: anagen prolongation and stimulation of both hair matrix keratinocyte proliferation and hair pigmentation. J Clin Endocrinol Metab (2008) 1.15

Retracted Signaling through P2X7 receptor in human T cells involves p56lck, MAP kinases, and transcription factors AP-1 and NF-kappa B. J Biol Chem (2002) 1.15

Lhx2 differentially regulates Sox9, Tcf4 and Lgr5 in hair follicle stem cells to promote epidermal regeneration after injury. Development (2011) 1.15

Receptor activator of NF-kappaB (RANK) stimulates the proliferation of epithelial cells of the epidermo-pilosebaceous unit. Proc Natl Acad Sci U S A (2011) 1.13

Hair growth inhibition by psychoemotional stress: a mouse model for neural mechanisms in hair growth control. Exp Dermatol (2006) 1.13

Structural and thermodynamic bases for the design of pure prolactin receptor antagonists: X-ray structure of Del1-9-G129R-hPRL. J Biol Chem (2007) 1.13

Hair follicle stem cells: walking the maze. Eur J Cell Biol (2007) 1.12

The lysosomal protease cathepsin L is an important regulator of keratinocyte and melanocyte differentiation during hair follicle morphogenesis and cycling. Am J Pathol (2002) 1.11

Cylindromatosis and the CYLD gene: new lessons on the molecular principles of epithelial growth control. Bioessays (2007) 1.11

How a cytokine is chaperoned through the secretory pathway by complexing with its own receptor: lessons from interleukin-15 (IL-15)/IL-15 receptor alpha. Mol Cell Biol (2008) 1.11

Development of pure prolactin receptor antagonists. J Biol Chem (2003) 1.11

Identification of a gain-of-function mutation of the prolactin receptor in women with benign breast tumors. Proc Natl Acad Sci U S A (2008) 1.10

Interleukin-21 inhibits dendritic cell-mediated T cell activation and induction of contact hypersensitivity in vivo. J Invest Dermatol (2003) 1.10

FOXN1 is critical for onycholemmal terminal differentiation in nude (Foxn1) mice. J Invest Dermatol (2004) 1.10

Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year. J Am Acad Dermatol (2007) 1.10

Mast cell-mediated antigen presentation regulates CD8+ T cell effector functions. Immunity (2009) 1.10